Maria Eugenia Cifuentes-Pagano

Title: Maria Eugenia Cifuentes-Pagano: Innovator in Pharmaceutical Chemistry

Introduction

Maria Eugenia Cifuentes-Pagano is a distinguished inventor based in Sewickley, Pennsylvania. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective inhibitors for NADPH oxidase 2. Her innovative work has led to the filing of two patents that showcase her expertise and dedication to advancing medical science.

Latest Patents

Cifuentes-Pagano's latest patents focus on tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors. These patents disclose embodiments of bridged tetrahydroisoquinolines and methods for their use in selectively inhibiting nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2. The disclosed compounds are characterized by a specific structure that includes various functional groups, allowing for targeted therapeutic applications.

Career Highlights

Maria Eugenia Cifuentes-Pagano is affiliated with the University of Pittsburgh, where she continues her research and development efforts. Her academic background and professional experience have positioned her as a leading figure in her field. She is committed to exploring new avenues for drug development and improving patient outcomes through her innovative research.

Collaborations

Cifuentes-Pagano has collaborated with notable colleagues, including Patrick Joseph Pagano and Peter Wipf. These partnerships have enhanced her research capabilities and contributed to the successful development of her patented inventions.

Conclusion

Maria Eugenia Cifuentes-Pagano exemplifies the spirit of innovation in pharmaceutical chemistry. Her work on selective NADPH oxidase 2 inhibitors represents a significant advancement in the field, and her contributions continue to inspire future research and development.